Comprehensive Evaluation of the Immune Risk Phenotype in Successfully Treated HIV-Infected Individuals

Open Access

Peer-reviewed

Research Article

Patricia Ndumbi ,

* E-mail: patricia.ndumbi@mail.mcgill.ca (PN); chris.tsoukas@muhc.mcgill.ca (CMT)

Affiliation Immune Deficiency Treatment Centre, McGill University Health Centre, Montreal, QC, Canada
⨯
Louise Gilbert,

Affiliation Immune Deficiency Treatment Centre, McGill University Health Centre, Montreal, QC, Canada
⨯
Christos M. Tsoukas

* E-mail: patricia.ndumbi@mail.mcgill.ca (PN); chris.tsoukas@muhc.mcgill.ca (CMT)

Affiliation Immune Deficiency Treatment Centre, McGill University Health Centre, Montreal, QC, Canada
⨯

Reader Comments (0)

T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Telomere length
Is the Subject Area "Telomere length" applicable to this article?

Thanks for your feedback.
Lymphocytes
Is the Subject Area "Lymphocytes" applicable to this article?

Thanks for your feedback.
Senescence
Is the Subject Area "Senescence" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Telomeres
Is the Subject Area "Telomeres" applicable to this article?

Thanks for your feedback.
HIV infections
Is the Subject Area "HIV infections" applicable to this article?

Thanks for your feedback.